Literature DB >> 22425921

Recurrence dynamics for non-small-cell lung cancer: effect of surgery on the development of metastases.

Romano Demicheli1, Marco Fornili, Federico Ambrogi, Kristin Higgins, Jessamy A Boyd, Elia Biganzoli, Chris R Kelsey.   

Abstract

INTRODUCTION: We study event rates over time (event dynamics) in patients undergoing surgery for early-stage non-small-cell lung cancer (NSCLC).
METHODS: Using a database of patients undergoing initial surgery for NSCLC, the event dynamics, based on the hazard rate, were evaluated. Events evaluated included time to any treatment failure, local recurrence, distant metastasis (DM), and development of a second primary lung cancer.
RESULTS: Among 1506 patients, time to any treatment failure dynamics demonstrated an initial surge in the hazard rate 9 months after surgery, followed by two smaller peaks at the end of the second and fourth years, respectively. This pattern was dominated by DM events. Two distinguishable peaks were noted for local recurrence in the first and second years. In contrast, the hazard rate for second primary lung cancer exhibited a more uniform pattern over time. The DM dynamics was analyzed by sex and three peaks emerged for both sexes. The timing of the first peak was similar for both sexes, at 7 to 9 months after surgery. The second peak occurred earlier in men (18-20 months) than women (24-26 months). For both sexes the third peak appeared during the fourth year.
CONCLUSIONS: Recurrence dynamics of resected early-stage NSCLC displays a multipeak pattern, which supports the hypothesis of a metastasis growth model previously described for early-stage breast cancer. The model assumes both cellular and micrometastatic tumor dormancy and a transient phase of acceleration of metastatic growth following surgical excision of the primary tumor.

Entities:  

Mesh:

Year:  2012        PMID: 22425921     DOI: 10.1097/JTO.0b013e31824a9022

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN: 1556-0864            Impact factor:   15.609


  50 in total

1.  Cons: long-term CT-scan follow-up is not the standard of care in patients curatively treated for an early stage non-small cell lung cancer.

Authors:  Jan P van Meerbeeck; Halil Sirimsi
Journal:  Transl Lung Cancer Res       Date:  2015-08

2.  Video-assisted thoracoscopic surgery versus sternotomy in thymectomy for thymoma and myasthenia gravis.

Authors:  Adnan Raza; Edwin Woo
Journal:  Ann Cardiothorac Surg       Date:  2016-01

3.  Sevoflurane suppresses hypoxia-induced growth and metastasis of lung cancer cells via inhibiting hypoxia-inducible factor-1α.

Authors:  Hua Liang; Cheng Xiang Yang; Bin Zhang; Han Bing Wang; Hong Zhen Liu; Xiao Hong Lai; Mei Juan Liao; Tao Zhang
Journal:  J Anesth       Date:  2015-05-23       Impact factor: 2.078

Review 4.  Classic "broken cell" techniques and newer live cell methods for cell cycle assessment.

Authors:  Lindsay Henderson; Dante S Bortone; Curtis Lim; Alexander C Zambon
Journal:  Am J Physiol Cell Physiol       Date:  2013-02-07       Impact factor: 4.249

5.  YAP1 Regulates OCT4 Activity and SOX2 Expression to Facilitate Self-Renewal and Vascular Mimicry of Stem-Like Cells.

Authors:  Namrata Bora-Singhal; Jonathan Nguyen; Courtney Schaal; Deepak Perumal; Sandeep Singh; Domenico Coppola; Srikumar Chellappan
Journal:  Stem Cells       Date:  2015-06       Impact factor: 6.277

6.  For a better adjuvant strategy for resected lung cancer-lessons from treatment failure patterns of the ADJUVANT trial (CTONG 1104).

Authors:  Kenichi Suda
Journal:  Transl Lung Cancer Res       Date:  2019-12

7.  Differences in patterns of recurrence in early-stage versus locally advanced non-small cell lung cancer.

Authors:  Feiran Lou; Camelia S Sima; Valerie W Rusch; David R Jones; James Huang
Journal:  Ann Thorac Surg       Date:  2014-08-07       Impact factor: 4.330

8.  Effect of Vein-First vs Artery-First Surgical Technique on Circulating Tumor Cells and Survival in Patients With Non-Small Cell Lung Cancer: A Randomized Clinical Trial and Registry-Based Propensity Score Matching Analysis.

Authors:  Shiyou Wei; Chenglin Guo; Jintao He; Qunyou Tan; Jiandong Mei; Zhenyu Yang; Chengwu Liu; Qiang Pu; Lin Ma; Yong Yuan; Feng Lin; Yunke Zhu; Hu Liao; Wenping Wang; Zheng Liu; Qiang Li; Bin Jiang; Chuan Li; Liang Xia; Kejia Zhao; Fanyi Gan; Jiahan Cheng; Zhu Wu; Yun Wang; Yidan Lin; Yingli Kou; Guowei Che; Longqi Chen; Jing Li; Lunxu Liu
Journal:  JAMA Surg       Date:  2019-07-17       Impact factor: 14.766

9.  Imaging surveillance and survival for surgically resected non-small-cell lung cancer.

Authors:  Leah M Backhus; Farhood Farjah; Chao-Kang Jason Liang; Hao He; Thomas K Varghese; David H Au; David R Flum; Steven B Zeliadt
Journal:  J Surg Res       Date:  2015-06-25       Impact factor: 2.192

10.  TASK-1 induces gefitinib resistance by promoting cancer initiating cell formation and epithelial-mesenchymal transition in lung cancer.

Authors:  Xing-Guang Wang; Na-Xin Yuan; Xin-Peng Li; Fang-Fang Chen
Journal:  Exp Ther Med       Date:  2017-11-01       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.